Press release - 11 September 2007
CapMan invests in Mawell
CapMan Technology 2007 fund announces an investment in ICT company Mawell. Mawell provides solutions that enhance patient safety, quality and productivity to private and public healthcare organisations and pharmaceutical industry mainly in the Nordic countries. The investment will finance the company’s international growth.
Mawell, established in 2001, provides software and services that are used in many Finnish and Swedish hospital districts and as a part of the product range of partners such as GE Healthcare and Agfa Healthcare in Europe, Middle East and Africa. The fast growing company targets a turnover of approx. EUR 10 million in 2007 and it employs 120 persons.
Mawell provides solutions in three complementary areas: Imaging and Clinical Data, Selfcare and eServices and Business Intelligence. With the assistance of Mawell’s M7, B7 and S7 solutions healthcare organisations can offer their clients innovative services such as e-consultations, e-healthcare services and health counselling. The web-based technology enables electronic handling of patient records and integration of different healthcare information management systems.
”The demand for e-healthcare services is growing with the ageing of the population, rising healthcare costs and development of technology solutions. Mawell’s solutions enable lower healthcare system costs without a trade-off in quality care. The company has grown strongly and we will focus on expansion of Mawell’s operations in selected geographical areas,” says CapMan Senior Advisor Jarkko Virtanen.
”The real time availability of patient data ensures improved patient care and increased healthcare productivity. High-quality treatment decisions can increasingly be made by transferring data instead of moving the patient. Mawell’s products provide a concrete solution to these challenges,” says Tero Silvola, CEO of Mawell. ”Solutions that are based on open standards facilitate seamless communication between different operator independent system environments, and have made the building of isolated systems in healthcare at the cost of patient safety and productivity a thing of the past.”
CapMan Technology 2007 fund will invest approx. EUR 8 million in Mawell and becomes the largest single owner of the company. CapMan Plc is a substantial investor in the fund. The transaction is expected to be finalised by the end of September.
For further information, please contact:
Jarkko Virtanen, Senior Advisor, CapMan Technology, tel. +358 9 6155 8369 or +358 40 547 6945
Tero Silvola, CEO, Mawell Oy, tel. +358 40 590 5733
‹ Back to previous page